Tanzeum Now Available for Type 2 Diabetes
Tanzeum, a glucagon-like peptide-1 (GLP-1) receptor agonist, is a once weekly treatment indicated for use in combination with other antidiabetic medications. It has been approved with a Risk Evauation and Mitigation Strategy (REMS) to ensure that the benefits outweigh the potential risk of medullary thyroid carcinoma and the risk of acute pancreatitis.
Tanzeum for subcutaneous injection is available as a 30mg or 50mg single-dose Pen in 4-count cartons.
For more information call (888) 825-5249 or visit Tanzeum.com.